Table 4.
Descriptive statistics of PH by continent and overall
| America | Europe | Overall | |
|---|---|---|---|
| Total | 3484 | 10,523 | 14,007 |
| Female | 2416 (71%) | 6273 (60%) | 8734 |
| Male | 1017 (29%) | 4248 (40%) | 5265 |
| Other gender | 6 (0%) | 2 (0%) | 8 (0%) |
| Observation period | |||
| 0–2 years | 1239 (40%) | 5955 (57%) | 7194 (53%) |
| 2–10 years | 1458 (47%) | 3726 (36%) | 5184 (38%) |
| >10 years | 417 (13%) | 742 (7%) | 1159 (9%) |
| Risk assessment 15 | |||
| Low risk | 982 (28%) | 2377 (23%) | 3359 (24%) |
| Intermediate risk | 2256 (65%) | 6464 (61%) | 8720 (62%) |
| High risk | 128 (4%) | 804 (8%) | 933 (7%) |
| (Not available) | 117 (3%) | 878 (8%) | 995 (7%) |
| 4‐strata risk assessment 14 | |||
| Low risk | 445 (13%) | 927 (9%) | 1372 (10%) |
| Intermediate‐low risk | 897 (26%) | 1287 (12%) | 2184 (16%) |
| Intermediate‐high risk | 1259 (36%) | 5096 (48%) | 6355 (45%) |
| High risk | 431 (12%) | 2276 (22%) | 2707 (19%) |
| (Not available) | 452 (12%) | 937 (9%) | 1389 (10%) |
Note: Percentages are calculated vertically.
Abbreviation: PH, pulmonary hypertension.